rs6775296

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001122752.2(SERPINI1):​c.-18-15999A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.128 in 151,390 control chromosomes in the GnomAD database, including 1,510 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.13 ( 1510 hom., cov: 30)

Consequence

SERPINI1
NM_001122752.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.35

Publications

1 publications found
Variant links:
Genes affected
SERPINI1 (HGNC:8943): (serpin family I member 1) This gene encodes a member of the serpin superfamily of serine proteinase inhibitors. The protein is primarily secreted by axons in the brain, and preferentially reacts with and inhibits tissue-type plasminogen activator. It is thought to play a role in the regulation of axonal growth and the development of synaptic plasticity. Mutations in this gene result in familial encephalopathy with neuroserpin inclusion bodies (FENIB), which is a dominantly inherited form of familial encephalopathy and epilepsy characterized by the accumulation of mutant neuroserpin polymers. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Jul 2008]
SERPINI1 Gene-Disease associations (from GenCC):
  • progressive myoclonus epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • familial encephalopathy with neuroserpin inclusion bodies
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.21 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SERPINI1NM_001122752.2 linkc.-18-15999A>G intron_variant Intron 1 of 8 ENST00000446050.7 NP_001116224.1
SERPINI1NM_005025.5 linkc.-18-15999A>G intron_variant Intron 1 of 8 NP_005016.1
SERPINI1XM_017006618.3 linkc.-18-15999A>G intron_variant Intron 1 of 8 XP_016862107.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SERPINI1ENST00000446050.7 linkc.-18-15999A>G intron_variant Intron 1 of 8 1 NM_001122752.2 ENSP00000397373.2
SERPINI1ENST00000295777.9 linkc.-18-15999A>G intron_variant Intron 1 of 8 1 ENSP00000295777.5
SERPINI1ENST00000472747.2 linkc.-18-15999A>G intron_variant Intron 1 of 4 3 ENSP00000420561.2
SERPINI1ENST00000472941.5 linkc.-18-15999A>G intron_variant Intron 1 of 2 3 ENSP00000420133.1

Frequencies

GnomAD3 genomes
AF:
0.128
AC:
19346
AN:
151276
Hom.:
1502
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.213
Gnomad AMI
AF:
0.0826
Gnomad AMR
AF:
0.120
Gnomad ASJ
AF:
0.0570
Gnomad EAS
AF:
0.0686
Gnomad SAS
AF:
0.0361
Gnomad FIN
AF:
0.151
Gnomad MID
AF:
0.0924
Gnomad NFE
AF:
0.0908
Gnomad OTH
AF:
0.107
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.128
AC:
19392
AN:
151390
Hom.:
1510
Cov.:
30
AF XY:
0.128
AC XY:
9482
AN XY:
73908
show subpopulations
African (AFR)
AF:
0.213
AC:
8789
AN:
41186
American (AMR)
AF:
0.120
AC:
1817
AN:
15172
Ashkenazi Jewish (ASJ)
AF:
0.0570
AC:
197
AN:
3458
East Asian (EAS)
AF:
0.0683
AC:
352
AN:
5150
South Asian (SAS)
AF:
0.0357
AC:
171
AN:
4788
European-Finnish (FIN)
AF:
0.151
AC:
1577
AN:
10476
Middle Eastern (MID)
AF:
0.0925
AC:
27
AN:
292
European-Non Finnish (NFE)
AF:
0.0908
AC:
6159
AN:
67866
Other (OTH)
AF:
0.109
AC:
228
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.526
Heterozygous variant carriers
0
784
1567
2351
3134
3918
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
210
420
630
840
1050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.109
Hom.:
131
Bravo
AF:
0.133
Asia WGS
AF:
0.0810
AC:
281
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.83
DANN
Benign
0.48
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6775296; hg19: chr3-167490900; API